Daniel G. Kaye
Director · CME GROUP INC.
IndividualSelling only
- 2025
- Jun 29, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel G. Kaye files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Pearson - $15.92M in EQH purchases and sales in the last 12 months
- Terrence A. Duffy - $14.56M in CME purchases and sales in the last 12 months
- Jeffrey J. Hurd - $4.81M in EQH purchases and sales in the last 12 months
- Nick Lane - $4.57M in EQH purchases and sales in the last 12 months
- Seth P. Bernstein - $2.25M in AB purchases and sales in the last 12 months
- Jonathan L. Marcus - $2.13M in CME purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel G. Kaye?
Daniel G. Kaye is a corporate insider, tracked as Director of CME GROUP INC. (CME). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Daniel G. Kaye last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 5 filings going back to 2025.
Has Daniel G. Kaye been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($141K) across all tracked filings.
